呼吸生物反馈与心理教育用于COVID-19后症状及躯体痛苦患者:随机对照探索性干预试验POSITIV研究方案
POSITIV是一项随机对照探索性干预试验,纳入符合WHO长新冠标准且伴躯体痛苦障碍的患者60例(每组30例),干预组接受6周视频会议团体认知行为治疗和4周移动呼吸生物反馈治疗,对照组为常规治疗。主要结局为自我效能感变化,次要结局包括心理健康、躯体症状和干预满意度。
要点
- 研究纳入符合WHO长新冠标准且伴躯体痛苦障碍的患者60例,随机分为干预组和对照组(各30例)。
- 干预组接受6周视频会议团体认知行为治疗和4周移动呼吸生物反馈治疗,对照组为常规治疗。
- 主要结局为自我效能感变化,次要结局包括心理健康、躯体症状和干预满意度。
核心结论
- POSITIV试验是针对长新冠伴心理负担患者的早期干预研究之一,旨在生成新证据并帮助患者应对疾病,从而提高生活质量并减轻症状。
- 作者预期干预后患者的自我效能感和健康状况很可能得到改善。
研究设计与样本
- 随机对照探索性干预试验,计划纳入60例符合WHO长新冠标准且伴躯体痛苦障碍的患者,每组30例,随机分为干预组和对照组(常规治疗)。
- 随机化在诊断性访谈、筛查和知情同意后进行。
- 干预组接受6周视频会议团体认知行为治疗和4周移动呼吸生物反馈治疗。
- 在多个时间点评估两组的心理和身体健康状况、治疗期望和干预满意度,并进行生物反馈检查预约。
- 数据主要使用R和SPSS进行分析。
关键数值与推荐
- 主要结局为自我效能感的变化。
- 次要结局包括心理健康、躯体症状和干预满意度评估参数。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A high number of individuals report suffering from physical and psychological sequelae symptoms after COVID-19-the so-called post COVID-19 condition. Commonly reported complaints include physical symptoms such as fatigue, headache, attention and concentration deficits or dyspnea and anxiety, symptoms of post-traumatic stress, or depression. Evidence-based treatment recommendations are still lacking up to this point. Associations between physical and psychological symptoms in chronic diseases are known for a long time. Support in coping with the disease and improvement of self-efficacy can have a positive effect on the course of diseases. For this reason, we designed a randomized, controlled explorative intervention trial as a treatment of bodily distress disorder in COVID-19 recovered persons. METHODS: Patients with a post COVID-19 condition meeting to the criteria of the WHO, along with a bodily distress disorder, are randomized in an intervention and control arm (TAU). Randomization takes place after a diagnostic interview, screening, and informed consent. In total, 60 patients will be included in the trial (30 per group). The intervention group receives a cognitive behavioral therapy as a video-conference-based group therapy (6 weeks) and mobile, respiratory biofeedback treatment (for 4 weeks). At several time points, both groups are assessed in terms of psychological and physical health status, treatment expectation, and satisfaction with the intervention. Furthermore, they will get biofeedback examination appointments. The primary outcome is the change in self-efficacy; secondary outcomes include assessed parameters of mental health, somatic symptoms, and satisfaction with the intervention. Data will be analyzed primarily using R and SPSS. DISCUSSION: The randomized, controlled, explorative intervention trial POSITIV is one of the very first interventions for patients with post COVID-19 condition and psychological burden due to their different symptoms. The aim of the study is to generate new evidence and help patients to cope with the disease and thus, increase their quality of life and reduce symptomatology. We expect with a high probability that the patients' self-efficacy and health status will improve as a result of the intervention. TRIAL REGISTRATION: German Clinical Trial Register (DRKS); DRKS-ID: DRKS00030565. Registered on December 22, 2022.
引用
- Dinse H, Skoda EM, Schweda A, et al. Respiratory biofeedback and psycho-education for patients with post COVID- 19 symptoms and bodily distress: study protocol of the randomized, controlled explorative intervention trial POSITIV. Trials. 2025. PMID: 40281597. doi:10.1186/s13063-025-08842-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。